Avantages
They participate in an important, growing field, which is on the verge of changing the way medicine is performed both in hospitals, reference labs, and maybe even point-of-care.
Their solution is creative, but has been described as "not ready" for the clinical marketplace.
Family company if you like that sort of thing.
Automation is the ultimate goal of the molecular diagnostics market place.
Inconvénients
Some influential managers are literal dinosaurs in the industry; they do not see how much their field has changed along with business practices. Subsequently, their metrics are wrong.
Their solution is a creative one, however has been described as "not ready" for the clinical marketplace.